Drug Type Small molecule drug |
Synonyms Xeruborbactam/Cefiderocol Sulfate Tosylate + [1] |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), Serine protease inhibitors, β-lactamase inhibitors(Beta Lactamase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC10H8BFO4 |
InChIKeyKOHUFVUIYUCFNG-PHDIDXHHSA-N |
CAS Registry2170834-63-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gram-Negative Bacterial Infections | Phase 1 | US | - | |
Infectious Diseases | Preclinical | JP | 01 Nov 2023 |